Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 08, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Tentative Approval for Efinaconazole Topical Solution, 10%".